{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:36:37Z","timestamp":1791308197694,"version":"4.3.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.ejca.2007.08.028","type":"journal-article","created":{"date-parts":[[2007,10,24]],"date-time":"2007-10-24T11:17:25Z","timestamp":1193224645000},"page":"46-53","source":"Crossref","is-referenced-by-count":282,"title":["Mesothelin targeted cancer immunotherapy"],"prefix":"10.1016","volume":"44","clinical-trial-number":[{"clinical-trial-number":"nct00325494","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Raffit","family":"Hassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2007.08.028_bib1","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1073\/pnas.93.1.136","article-title":"Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers","volume":"93","author":"Chang","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ejca.2007.08.028_bib2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ijc.2910500308","article-title":"Isolation and characterization of a monoclonal antibody, K1, reactive with ovarian cancers and normal mesothelium","volume":"50","author":"Chang","year":"1992","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2007.08.028_bib3","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/01.MP.0000056981.16578.C3","article-title":"Value of mesothelin immunostaining in the diagnosis of mesothelioma","volume":"16","author":"Ordonez","year":"2003","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ejca.2007.08.028_bib4","first-page":"3862","article-title":"Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE)","volume":"7","author":"Argani","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2007.08.028_bib5","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/01.pai.00000141545.36485.d6","article-title":"Localization of mesothelin in epithelial ovarian cancer","volume":"13","author":"Hassan","year":"2005","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.ejca.2007.08.028_bib6","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1097\/00000478-200311000-00003","article-title":"Application of mesothelin immunostaining in tumor diagnosis","volume":"27","author":"Ordonez","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejca.2007.08.028_bib7","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1158\/1078-0432.CCR-03-0801","article-title":"Mesothelin: a new target for immunotherapy","volume":"10","author":"Hassan","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2007.08.028_bib8","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0021-9258(17)42180-6","article-title":"A novel cytokine exhibiting megakaryocyte potentiating activity from a human pancreatic tumor cell line HPC-Y5","volume":"269","author":"Yamaguchi","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejca.2007.08.028_bib9","doi-asserted-by":"crossref","first-page":"9190","DOI":"10.1074\/jbc.M312372200","article-title":"Binding of ovarian cancer antigen CA125\/MUC16 to mesothelin mediates cell adhesion","volume":"279","author":"Rump","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejca.2007.08.028_bib10","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1158\/1078-0432.CCR-05-1477","article-title":"Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer","volume":"12","author":"Hassan","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2007.08.028_bib11","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/S0140-6736(03)14794-0","article-title":"Mesothelin-family proteins and diagnosis of mesothelioma","volume":"362","author":"Robinson","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2007.08.028_bib12","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00000478-199203000-00006","article-title":"Monoclonal antibody K1 reacts with epithelial mesothelioma but not lung adenocarcinoma","volume":"16","author":"Chang","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejca.2007.08.028_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2006.08.010","article-title":"What are the current best immunohistochemical markers for the diagnosis of epithelioid mesothelioma: a review and update","volume":"38","author":"Ordanez","year":"2007","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ejca.2007.08.028_bib14","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1309\/F1B64CL7H8VJKEAF","article-title":"Mesothelin is overexpressed in pancreaticobiliary adenocarcinomas but not in normal pancreas and chronic pancreatitis","volume":"124","author":"Hassan","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ejca.2007.08.028_bib15","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.humpath.2003.10.012","article-title":"Analysis of novel tumor markers in pancreatic and biliary carcinomas using tissue microarrays","volume":"35","author":"Swierczynski","year":"2004","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ejca.2007.08.028_bib16","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0046-8177(03)00177-1","article-title":"Large-scale molecular and tissue microarray analysis of mesothelin expression in common human carcinomas","volume":"34","author":"Frierson","year":"2003","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ejca.2007.08.028_bib17","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/00000478-200302000-00002","article-title":"Expression of calretinin, thrombomodulin, keratin 5, and meosthelin in lung carcinomas of different types: an immunohistochemical analysis of 596 tumors in comparison with epithelioid mesotheliomas of the pleura","volume":"27","author":"Miettinen","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejca.2007.08.028_bib18","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1158\/1078-0432.CCR-06-2161","article-title":"Mesothelin expression in human lung cancer","volume":"13","author":"Ho","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2007.08.028_bib19","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/ijc.2910510408","article-title":"Frequent expression of the tumor antigen CAK1 in squamous-cell carcinomas","volume":"51","author":"Chang","year":"1992","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2007.08.028_bib20","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ygyno.2006.10.063","article-title":"Overexpression of folate binding protein and mesothelin are associated with uterine serous carcinoma","volume":"105","author":"Dainty","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejca.2007.08.028_bib21","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1128\/MCB.20.8.2902-2906.2000","article-title":"Mesothelin is not required for normal mouse development or reproduction","volume":"20","author":"Bera","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.ejca.2007.08.028_bib22","doi-asserted-by":"crossref","first-page":"27371","DOI":"10.1074\/jbc.M103554200","article-title":"Molecular cloning of the CA 125 ovarian cancer antigen: identification as a new mucin, MUC16","volume":"276","author":"Yin","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejca.2007.08.028_bib23","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJM198310133091503","article-title":"A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer","volume":"309","author":"Bast","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2007.08.028_bib24","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1476-4598-5-50","article-title":"Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors","volume":"5","author":"Gubbels","year":"2006","journal-title":"Mol Cancer"},{"key":"10.1016\/j.ejca.2007.08.028_bib25","doi-asserted-by":"crossref","first-page":"7860","DOI":"10.1038\/sj.onc.1203245","article-title":"Mechanism and function of signal transduction by the Wnt\/\u03b2-catenin and Wnt\/Ca2+ pathways","volume":"18","author":"Miller","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.ejca.2007.08.028_bib26","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-213X-3-2","article-title":"Stromelysin-1 and mesothelin are differentially regulated by Wnt-5a and Wnt-1 in C57MG mouse mammary epithelial cells","volume":"3","author":"Prieve","year":"2003","journal-title":"BMC Dev Biol"},{"key":"10.1016\/j.ejca.2007.08.028_bib27","first-page":"4547","article-title":"Evidence of dishevelled overexpression and transcriptional activity of \u03b2-catenin","volume":"63","author":"Uematsu","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2007.08.028_bib28","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1158\/1078-0432.CCR-04-2304","article-title":"Humoral immune response to mesothelin in mesothelioma and ovarian cancer patients","volume":"11","author":"Ho","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2007.08.028_bib29","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1158\/1078-0432.CCR-05-1397","article-title":"Diffuse mesothelin expression correlates with prolonged patient survival in ovarian serous carcinoma","volume":"12","author":"Yen","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2007.08.028_bib30","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1073\/pnas.95.2.669","article-title":"Isolation of a high-affinity stable single-chain Fv specific for mesothelin from DNA-immunized mice by phage display and construction of a recombinant immunotoxin with anti-tumor activity","volume":"95","author":"Chowdhury","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ejca.2007.08.028_bib31","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/9872","article-title":"Improving antibody affinity by mimicking somatic hypermutation in vitro","volume":"17","author":"Chowdhury","year":"1999","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.ejca.2007.08.028_bib32","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nrc1891","article-title":"Immunotoxin therapy of cancer","volume":"6","author":"Pastan","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ejca.2007.08.028_bib33","first-page":"3520","article-title":"Antitumor activity of SS(dsFv)PE38 and SS1(dsFv)PE38, recombinant antimesothelin immunotoxins against human gynecologic cancers grown in organotypic culture in vitro","volume":"8","author":"Hassan","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2007.08.028_bib34","first-page":"1327","article-title":"Cytotoxic activity of the recombinant anti-mesothelin immunotoxin, SS1(dsFv)PE38 towards tumor cell lines established from ascites of patient with peritoneal mesotheliomas","volume":"24","author":"Li","year":"2004","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejca.2007.08.028_bib35","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1158\/1078-0432.CCR-06-0441","volume":"12","author":"Hassan","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2007.08.028_bib36","doi-asserted-by":"crossref","first-page":"4695","DOI":"10.1158\/1078-0432.CCR-06-0346","article-title":"Synergistic antitumor activity of taxol and immunotoxin SS1P in tumor-bearing mice","volume":"12","author":"Zhang","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2007.08.028_bib37","doi-asserted-by":"crossref","first-page":"5144","DOI":"10.1158\/1078-0432.CCR-07-0869","article-title":"Phase I study of SS1P, a recombinant anti-mesothelin immunotoxin given as a bolus i.v. infusion to patients with mesothelin-expressing mesothelioma, ovarian, and pancreatic cancers","volume":"13","author":"Hassan","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"Suppl.","key":"10.1016\/j.ejca.2007.08.028_bib38","doi-asserted-by":"crossref","first-page":"14041","DOI":"10.1200\/jco.2007.25.18_suppl.14041","volume":"25","author":"Armstrong","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2007.08.028_bib39","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1084\/jem.20031435","article-title":"Mesothelin-specific CD8(+) T cell response provide evidence of in vivo cross-priming by antigen-presenting cells in vaccinated pancreatic cancer patients","volume":"200","author":"Thomas","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.ejca.2007.08.028_bib40","doi-asserted-by":"crossref","first-page":"13832","DOI":"10.1073\/pnas.0406035101","article-title":"Listeria-based cancer vaccines that segregate immunogenicity from toxicity","volume":"101","author":"Brockstedt","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ejca.2007.08.028_bib41","unstructured":"Giedlin MA, Bahjat KS, Prell RA, et al. Activation and expansion of hepatic NK cells promotes innate antitumor immunity and long-lived CD8+ T cell memory following treatment with attenuated Listeria monocytogenes. AACR Proceedings (Abstract #1877), April 14, 2007."},{"key":"10.1016\/j.ejca.2007.08.028_bib42","unstructured":"Brockstedt DG, Leong ML, Bahjat KS, et al: Live-attenuated L. monocytogenes encoding mesothelin for immunotherapy of patients with pancreas and ovarian cancers. In: AACR proceedings (abstract #1874), April 14; 2007."},{"key":"10.1016\/j.ejca.2007.08.028_bib43","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1200\/JCO.2001.19.1.145","article-title":"Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation","volume":"19","author":"Jaffee","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2007.08.028_bib44","doi-asserted-by":"crossref","first-page":"6342","DOI":"10.1158\/1078-0432.CCR-05-0596","article-title":"Identification of novel human CTL epitopes and their agonist epitopes of mesothelin","volume":"11","author":"Yokokawa","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2007.08.028_bib45","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/sj.gt.3302404","article-title":"Mesothelin-mediated targeting of adenoviral vectors for ovarian cancer gene therapy","volume":"12","author":"Breidenbach","year":"2005","journal-title":"Gene Ther"},{"key":"10.1016\/j.ejca.2007.08.028_bib46","first-page":"1201","article-title":"Pretargeted radioimmunotherapy of mesothelin-expressing cancer using a tetravalent single-chain Fv-streptavidin fusion protein","volume":"46","author":"Sato","year":"2005","journal-title":"J Nucl Med"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095980490700696X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095980490700696X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T03:50:17Z","timestamp":1629949817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095980490700696X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S095980490700696X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2007.08.028","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}